These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 29914399)
1. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. Lima Martins A; Volpato RA; Zago-Gomes MDP BMC Gastroenterol; 2018 Jun; 18(1):87. PubMed ID: 29914399 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil. Martins AL; Fróes RSB; Zago-Gomes MDP World J Clin Pediatr; 2022 Jul; 11(4):341-350. PubMed ID: 36052115 [TBL] [Abstract][Full Text] [Related]
3. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184 [TBL] [Abstract][Full Text] [Related]
4. [Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad)]. Tourtelier Y; Dabadie A; Tron I; Alexandre JL; Robaskiewicz M; Cruchant E; Seyrig JA; Heresbach D; Bretagne JF Arch Pediatr; 2000 Apr; 7(4):377-84. PubMed ID: 10793924 [TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885 [TBL] [Abstract][Full Text] [Related]
6. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G; J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong. Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study. Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F; J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Garrido A; Martínez MJ; Ortega JA; Lobato A; Rodríguez MJ; Guerrero FJ Rev Esp Enferm Dig; 2004 Oct; 96(10):687-91; 691-4. PubMed ID: 15537375 [TBL] [Abstract][Full Text] [Related]
12. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Ng SC; Tang W; Ching JY; Wong M; Chow CM; Hui AJ; Wong TC; Leung VK; Tsang SW; Yu HH; Li MF; Ng KK; Kamm MA; Studd C; Bell S; Leong R; de Silva HJ; Kasturiratne A; Mufeena MNF; Ling KL; Ooi CJ; Tan PS; Ong D; Goh KL; Hilmi I; Pisespongsa P; Manatsathit S; Rerknimitr R; Aniwan S; Wang YF; Ouyang Q; Zeng Z; Zhu Z; Chen MH; Hu PJ; Wu K; Wang X; Simadibrata M; Abdullah M; Wu JC; Sung JJY; Chan FKL; Gastroenterology; 2013 Jul; 145(1):158-165.e2. PubMed ID: 23583432 [TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. Zeng Z; Zhu Z; Yang Y; Ruan W; Peng X; Su Y; Peng L; Chen J; Yin Q; Zhao C; Zhou H; Yuan S; Hao Y; Qian J; Ng SC; Chen M; Hu P J Gastroenterol Hepatol; 2013 Jul; 28(7):1148-53. PubMed ID: 23432198 [TBL] [Abstract][Full Text] [Related]
14. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Kurti Z; Vegh Z; Golovics PA; Fadgyas-Freyler P; Gecse KB; Gonczi L; Gimesi-Orszagh J; Lovasz BD; Lakatos PL Dig Liver Dis; 2016 Nov; 48(11):1302-1307. PubMed ID: 27481587 [TBL] [Abstract][Full Text] [Related]
15. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I; Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases. Holko P; Kawalec P; Stawowczyk E Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):456-464. PubMed ID: 29256907 [TBL] [Abstract][Full Text] [Related]
17. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Quaresma AB; Damiao AOMC; Coy CSR; Magro DO; Hino AAF; Valverde DA; Panaccione R; Coward SB; Ng SC; Kaplan GG; Kotze PG Lancet Reg Health Am; 2022 Sep; 13():100298. PubMed ID: 36777324 [TBL] [Abstract][Full Text] [Related]
18. [Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain]. Saro Gismera C; Riestra Menéndez S; Milla Crespo A; Sánchez Fernández R; Lacort Fernández M; Argüelles Fernández G; Chovac Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL An Med Interna; 2003 Jan; 20(1):3-9. PubMed ID: 12666301 [TBL] [Abstract][Full Text] [Related]
19. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study. Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil. Cassol OS; Zabot GP; Saad-Hossne R; Padoin A World J Gastroenterol; 2022 Aug; 28(30):4174-4181. PubMed ID: 36157112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]